Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients

被引：0
|
作者：
Dong Woo Shin
Minseok Albert Kim
Jong-chan Lee
Jaihwan Kim
Jin-Hyeok Hwang
机构：
[1] Seoul National University College of Medicine,Department of Internal Medicine
[2] Seoul National University Bundang Hospital,Division of Gastroenterology, Department of Internal Medicine
[3] Keimyung University School of Medicine,Department of Internal Medicine
[4] Keimyung University Dongsan Medical Center,undefined
[5] Seoul National University College of Medicine,undefined
[6] Seoul National University Hospital,undefined
来源：
BMC Research Notes | / 14卷
关键词：
Locally advanced pancreatic cancer; Skeletal muscle; Adipose tissue; Prognosis; FOLFIRINOX;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Tryptophan is the prognostic factor in patients with unresectable pancreatic cancer
    Saito, Kei
    Mizuno, Suguru
    Nakai, Yousuke
    Suzuki, Tatsunori
    Ishigaki, Kazunaga
    Hakuta, Ryunosuke
    Takahara, Naminatsu
    Saito, Tomotaka
    Hamada, Tsuyoshi
    Isayama, Hiroyuki
    Fujishiro, Mitsuhiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1434 - S1434
  • [42] Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Shin, Bang Sup
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Kwon, Wooil
    Jang, Jin-Young
    Kim, Sun-Whe
    GUT AND LIVER, 2021, 15 (02) : 315 - 323
  • [43] Sarcopenia in patients with pancreatic cancer, an independant prognostic factor
    Mandl, Johanna
    Baumer, Sebastian
    Holtzem, Bernadette
    Theurer, Rainer
    Zorger, Niels
    Pech, Oliver
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (10): : 1365 - 1370
  • [44] Prognostic Utility of Skeletal Muscle Mass Metrics in Patients With Heart Failure
    Uchida, Shota
    Kamiya, Kentaro
    Hamazaki, Nobuaki
    Nozaki, Kohei
    Ichikawa, Takafumi
    Yamashita, Masashi
    Noda, Takumi
    Ueno, Kensuke
    Hotta, Kazuki
    Maekawa, Emi
    Yamaoka-Tojo, Minako
    Matsunaga, Atsuhiko
    Ako, Junya
    CANADIAN JOURNAL OF CARDIOLOGY, 2023, 39 (11) : 1630 - 1637
  • [45] Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer
    Stene, Guro B.
    Helbostad, Jorunn L.
    Amundsen, Tore
    Sorhaug, Sveinung
    Hjelde, Harald
    Kaasa, Stein
    Gronberg, Bjorn H.
    ACTA ONCOLOGICA, 2015, 54 (03) : 340 - 348
  • [46] Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
    Martin, Lisa
    Birdsell, Laura
    MacDonald, Neil
    Reiman, Tony
    Clandinin, M. Thomas
    McCargar, Linda J.
    Murphy, Rachel
    Ghosh, Sunita
    Sawyer, Michael B.
    Baracos, Vickie E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (12) : 1539 - 1547
  • [47] Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival
    Judge, Sarah M.
    Nosacka, Rachel L.
    Delitto, Daniel
    Gerber, Michael H.
    Cameron, Miles E.
    Trevino, Jose G.
    Judge, Andrew R.
    JNCI CANCER SPECTRUM, 2018, 2 (03)
  • [48] Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer
    Daly, Louise E.
    Ni Bhuachalla, Eadaoin B.
    Power, Derek G.
    Cushen, Samantha J.
    James, Karl
    Ryan, Aoife M.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2018, 9 (02) : 315 - 325
  • [49] Prognostic Value of Pretreatment Skeletal Muscle Mass Index in Esophageal Cancer Patients: A Meta-Analysis
    Yao, Li
    Wang, Lei
    Yin, Yuanyuan
    Che, Guowei
    Yang, Mei
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (10): : 3592 - 3600
  • [50] Low skeletal muscle mass is a strong predictive factor for surgical complications and a prognostic factor in oral cancer patients undergoing mandibular reconstruction with a free fibula flap
    Ansari, E.
    Chargi, N.
    van Gemert, J. T. M.
    van Es, R. J. J.
    Dieleman, F. J.
    Rosenberg, A. J. W. P.
    Van Cann, E. M.
    de Bree, R.
    ORAL ONCOLOGY, 2020, 101
12345